LOXL4 Antibodies

Santa Cruz Biotechnology features a diverse variety of LOXL4 monoclonal antibodies for investigating lysyl oxidase-like 4 (LOXL4) in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LOXL4 belongs to the lysyl oxidase family and plays an essential role in cross-linking collagen and elastin within the extracellular matrix, which influences tissue structure and integrity. Research has shown LOXL4's involvement in various physiological and pathological processes, including fibrosis and cancer progression, highlighting its significance as a target for therapeutic intervention and biomarker discovery. Understanding LOXL4's expression patterns can provide critical information about tissue development and disease progression. Investigating LOXL4's molecular interactions helps reveal its role in maintaining extracellular matrix stability. Studying LOXL4's regulation mechanisms offers insights into potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance their understanding of LOXL4's role in human health and disease, contributing to meaningful discoveries in biomedical research.